SCHEMBL17600565

SCHEMBL17600565

CCCCCCc1ccc(-c2ccc3ccccc3n2)cc1.CCCCCCc1ccc(-c2ccc3ccccc3n2)cc1.CCCCCCc1ccc(-c2ccc3ccccc3n2)cc1.[Ir]

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 7/20 0.50
NPC1 O15118 5/20 0.50
SMN1; SMN2 Q16637 5/20 0.50
KDM4E B2RXH2 4/20 0.50
ALDH1A1 P00352 3/20 0.50
MEN1 O00255 3/20 0.50
KMT2A Q03164 3/20 0.50
AR P10275 2/20 0.50
DHODH Q02127 1/20 0.50
NFKB1 P19838 1/20 0.50
NFKB2 Q00653 1/20 0.50
RELA Q04206 1/20 0.50
MAPT P10636 6/20 0.49
CYP3A4 P08684 2/20 0.49
HPGD P15428 2/20 0.49
HSD17B10 Q99714 2/20 0.49
GMNN O75496 1/20 0.49
TP53 P04637 1/20 0.49
PKM P14618 1/20 0.49
THPO P40225 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28831219 1.00 RAB9A (0.50) RAB9ANPC1SMN1; SMN2KDM4EALDH1A1
SCHEMBL21359812 1.00 RAB9A (0.50) RAB9ANPC1SMN1; SMN2KDM4EALDH1A1
SCHEMBL29457610 0.99 RAB9A (0.51) RAB9ANPC1SMN1; SMN2KDM4EALDH1A1
SCHEMBL13729402 0.99 RAB9A (0.51) RAB9ANPC1SMN1; SMN2KDM4EALDH1A1
SCHEMBL31354840 0.97 RAB9A (0.50) RAB9ANPC1SMN1; SMN2KDM4EALDH1A1
SCHEMBL31619486 0.97 RAB9A (0.50) RAB9ANPC1SMN1; SMN2KDM4EALDH1A1
SCHEMBL29924645 0.97 RAB9A (0.50) RAB9ANPC1SMN1; SMN2KDM4EALDH1A1
SCHEMBL30524538 0.97 RAB9A (0.50) RAB9ANPC1SMN1; SMN2KDM4EALDH1A1
SCHEMBL28248377 0.97 RAB9A (0.53) RAB9ANPC1SMN1; SMN2KDM4EALDH1A1
SCHEMBL30847775 0.93 DHODH (0.56) RAB9ANPC1SMN1; SMN2KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12581792-B2 Organic light emitting diode and organic light emitting device having thereof LG DISPLAY CO., LTD. (KR) 2026-03-17 US disclosed
CN-119930662-A Polycyclic aromatic compound, organic electroluminescent element, display device, and lighting device 爱思开新材料捷恩智株式会社 2025-05-06 CN disclosed
CN-119431286-A Compound containing heterocycle and organic electroluminescent device thereof 长春海谱润斯科技股份有限公司 2025-02-14 CN disclosed
CN-119330956-A Azacarbazole compound and organic electroluminescent device thereof 长春海谱润斯科技股份有限公司 2025-01-21 CN disclosed
CN-118515654-A Triarylamine compound and organic electroluminescent device thereof 长春海谱润斯科技股份有限公司 2024-08-20 CN disclosed
US-20240244967-A1 Organic Light Emitting Diode and Organic Light Emitting Device Including the Same LG DISPLAY CO., LTD. (KR) 2024-07-18 US disclosed
US-20240244971-A1 ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME LG DISPLAY CO., LTD. (KR) 2024-07-18 US disclosed
US-20240244871-A1 ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME LG DISPLAY CO., LTD. (KR) 2024-07-18 US disclosed
US-20240244857-A1 ORGANIC COMPOUND, ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DEVICE HAVING THE COMPOUND LG DISPLAY CO., LTD. (KR) 2024-07-18 US disclosed
US-20240244970-A1 ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME LG DISPLAY CO., LTD. (KR) 2024-07-18 US disclosed
EP-3121163-A1 OLIGOANILINE DERIVATIVE, CHARGE-TRANSPORTING VARNISH, AND ORGANIC ELECTROLUMINESCENT ELEMENT Nissan Chemical Industries, Ltd. (JP) 2017-01-25 EP disclosed
US-20170005272-A1 ANILINE DERIVATIVE AND USE THEREOF NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2017-01-05 US disclosed
US-20160301011-A1 ANILINE DERIVATIVES AND USES THEREOF NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2016-10-13 US disclosed
US-20160293893-A1 ORGANIC ELECTROLUMINESCENT ELEMENT NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2016-10-06 US disclosed
US-20160248018-A1 ARYLSULFONIC ACID COMPOUND, USE THEREOF, AND METHOD FOR PRODUCING ARYLSULFONIC ACID COMPOUND NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2016-08-25 US disclosed
US-20160248017-A1 CHARGE-TRANSPORTING VARNISH NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2016-08-25 US disclosed
EP-3056484-A1 ARYLSULFONIC ACID COMPOUND, USE THEREOF, AND METHOD FOR PRODUCING ARYLSULFONIC ACID COMPOUND Nissan Chemical Industries, Ltd. (JP) 2016-08-17 EP disclosed
EP-3053910-A1 ANILINE DERIVATIVES AND USES THEREOF Nissan Chemical Industries, Ltd. (JP) 2016-08-10 EP disclosed
US-20160141507-A1 ANILINE DERIVATIVE, CHARGE-TRANSPORTING VARNISH AND ORGANIC ELECTROLUMINESCENT DEVICE NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2016-05-19 US disclosed
US-20160087220-A1 TRIPHENYLAMINE DERIVATIVE AND USE THEREFOR NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2016-03-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170005272-A1 ANILINE DERIVATIVE AND USE THEREOF SLC43A1, SLC7A5, SLC18A1 RAB9A 1413/4885NPC1 187/4885SMN1; SMN2 4014/4885
US-20160248018-A1 ARYLSULFONIC ACID COMPOUND, USE THEREOF, AND METHOD FOR PRODUCING ARYLSULFONIC ACID COMPOUND ARSA, SULT2A1, SULT1A1 RAB9A 1886/4885NPC1 1996/4885SMN1; SMN2 2136/4885
US-20160301011-A1 ANILINE DERIVATIVES AND USES THEREOF SLC18A1, SLC18A2, SLC43A1 RAB9A 2317/4885NPC1 910/4885SMN1; SMN2 4167/4885
US-20160141507-A1 ANILINE DERIVATIVE, CHARGE-TRANSPORTING VARNISH AND ORGANIC ELECTROLUMINESCENT DEVICE SLC7A5, SLC43A1, SLC9A5 RAB9A 505/4885NPC1 899/4885SMN1; SMN2 4280/4885
US-20160087220-A1 TRIPHENYLAMINE DERIVATIVE AND USE THEREFOR SLC7A1, SLC7A5, SLC7A11 RAB9A 4006/4885NPC1 1139/4885SMN1; SMN2 3647/4885
US-12581792-B2 Organic light emitting diode and organic light emitting device having thereof LPO, LIN28A, OCIAD2 RAB9A 884/4885NPC1 2078/4885SMN1; SMN2 3391/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.